IP Library Granted Patent US 10,016,454
Granted Patent B2
US 10,016,454 · App. 13/693,218 · Granted Jul 10, 2018

Silane-containing moisture-curable tissue sealant

Inventors: Dottie Clower (Pittsburgh, PA); Despina Dobbins (Gibsonia, PA); Stephanie Kladakis (Pittsburgh, PA)
Assignee: Cohera Medical, Inc.
A61K31/80F04C2270/0421
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,016,454
App. No.
13/693,218
Granted
Jul 10, 2018
Kind
B2
Abstract

A tissue sealant that includes the reaction product of (a) a polyol; (b) a polyisocyanate; and (c) an alkoxy silane having the formula: (R 1 R 2 R 3 )—Si—CH 2 —Z where (i) Z is an —OH, —SH, —NCO, or —NHR 4 group, where R 4 is hydrogen, an alkyl group, or an aryl group; and (ii) each R 1 , R 2 , and R 3 , independently, is H, an alkoxy group, an alkyl group, a heteroalkyl group other than an alkoxy group, an aryl group, or a heteroaryl group, with the proviso that at least two of R 1 , R 2 , and R 3 are alkoxy groups, the relative amounts of the polyol, polyisocyanate, and alkoxy silane being selected such that the reaction product comprises free isocyanate groups. The tissue sealant is moisture-curable and biodegradable in a physiological environment.

Claims (28)

1. A tissue sealant comprising the reaction product of:

(a) a polyol;

(b) a polyisocyanate selected from the group consisting of lysine diisocyanate and derivatives thereof, lysine triisocyanate and derivatives thereof, and combinations thereof; and

(c) an alkoxy silane having the formula: (R 1 R 2 R 3 )—Si—CH 2 —Z where:

(i) Z is an —OH, —SH, —NCO, or —NHR 4 group, where R 4 is hydrogen, an alkyl group, or an aryl group; and

(ii) each R 1 , R 2 , and R 3 , independently, is H, an alkoxy group, an alkyl group, a heteroalkyl group other than an alkoxy group, an aryl group, or a heteroaryl group, with the proviso that at least two of R 1 , R 2 , and R 3 are alkoxy groups,

wherein the relative amounts of the polyol, polyisocyanate, and alkoxy silane are selected such that the number of isocyanate groups available for reaction is greater than the number of isocyanate-reactive groups available for reaction selected from the group consisting of —OH groups, —SH groups, —NHR 4 groups, and combinations thereof, and produces a reaction product that comprises free isocyanate groups,

wherein the tissue sealant is moisture-curable and biodegradable in a physiological environment.

2. A tissue sealant according to claim 1 further comprising an isocyanate-functional organosilane having at least one free isocyanate group and at least one terminal silane group having the formula: (R 5 R 6 R 7 )—Si— where each R 5 , R 6 , and R 7 , independently, is H, an alkoxy group, an alkyl group, a heteroalkyl group other than an alkoxy group, an aryl group, or a heteroaryl group.

3. A tissue sealant according to claim 2 wherein the isocyanate-functional organosilane has a molecular weight no greater than 500 g/mole.

4. A tissue sealant according to claim 2 wherein the isocyanate-functional organosilane has a molecular weight no greater than 300 g/mole.

5. A tissue sealant according to claim 2 wherein the isocyanate-functional organosilane has the formula: (R 5 R 6 R 7 )—Si—R 8 —NCO where R 8 is a C 1 -C 10 alkyl group.

6. A tissue sealant according to claim 1 wherein two of R 1 , R 2 , and R 3 are C 1 -C 6 alkoxy groups.

7. A tissue sealant according to claim 1 wherein each of R 1 , R 2 , and R 3 is a C 1 -C 6 alkoxy group.

8. A tissue sealant according to claim 1 wherein Z is an —NHR 4 group.

9. A tissue sealant according to claim 8 where R 4 is a phenyl group.

10. A tissue sealant according to claim 2 wherein at least one of R 5 , R 6 , and R 7 is a C 1 -C 6 alkoxy group.

11. A tissue sealant according to claim 2 wherein each of R 5 , R 6 , and R 7 is a C 1 -C 6 alkoxy group.

12. A tissue sealant according to claim 2 wherein each of R 5 , R 6 , and R 7 is a C 1 -C 6 alkoxy group, and the isocyanate-functional organosilane has the formula: (R 5 R 6 R 7 )—Si—R 8 —NCO where R 8 has the formula: —(CH 2 ) n — where n=1-10.

13. A tissue sealant according to claim 1 wherein the polyol is selected from the group consisting of polyether polyols, polyester polyols, co-polyester polyether polyols, alkoxylated glycerol derivatives, and combinations thereof.

14. A tissue sealant according to claim 1 wherein the tissue sealant comprises the reaction product of the alkoxy silane, the polyisocyanate, and at least two different polyols.

15. A tissue sealant according to claim 1 , wherein the tissue sealant further comprises at least one reagent selected from the group consisting of solvents, diluents, catalysts, coagulants, and combinations thereof.

16. A tissue sealant according to claim 1 , wherein the tissue sealant further comprises a colorant.

17. A tissue sealant according to claim 16 , wherein the colorant comprises beta-carotene.

18. A method of sealing tissue comprising:

(a) applying a sealant according to claim 1 to a tissue surface; and

(b) curing the sealant to seal the area of tissue to which the sealant was applied.

19. A tissue sealant according to claim 1 , wherein the tissue sealant further comprises ethyl pyruvate.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2019
From: COHERA MEDICAL, INC.
To: DSI ASSIGNMENTS
Reel/Frame 051318/0730 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2019
From: DSI ASSIGNMENTS, LLC
To: ARTHREX, INC.
Reel/Frame 051318/0757 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 7, 2017
From: COHERA MEDICAL, INC.
To: KKR CHROME INVESTORS L.P.
Reel/Frame 043460/0502 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2013
From: CLOWER, DOTTIE; DOBBINS, DESPINA; KLADAKIS, STEPHANIE
To: COHERA MEDICAL, INC.
Reel/Frame 031535/0712 →
Continuity (1)
Related Publication 20140154204A1 · Jun 5, 2014